The Q2 continued to show an overall improvement in the group’s business, even prompting SZU to revise up its revenue guidance. On the other hand, costs are starting to weigh. No upgrade to the EBIT and EBITDA guidance.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
H2 does not bode so well
The Q2 continued to show an overall improvement in the group’s business, even prompting SZU to revise up its revenue guidance. On the other hand, costs are starting to weigh. No upgrade to the EBIT and EBITDA guidance.